BACKGROUND: Women affected with breast cancer who carry a BRCA1 or BRCA2 (BRCA1/2) mutation are at risk of developing contralateral breast cancer. To reduce the risk of contralateral breast cancer, some patients opt for prophylactic surgery of the unaffected breast (contralateral prophylactic mastectomy, CPM) in addition to mastectomy of the affected breast. METHODS: We conducted the present study to determine the predictors and outcomes of CPM in the year following BRCA1/2 genetic counseling and testing. Four hundred and thirty-five women affected with unilateral breast cancer who received positive or uninformative BRCA1/2 genetic test results completed assessments prior to genetic counseling and testing and 1, 6, and 12 months after receipt of results. RESULTS: Prior to testing, 16% had undergone CPM (in conjunction with mastectomy of the affected breast). In the year following testing, 18% with positive test results and 3% with uninformative test results opted for CPM. CPM following testing was associated with a positive genetic test result, younger age at cancer diagnosis [odds ratio (OR) = 0.94], and higher cancer-specific distress at baseline (OR = 3.28). CPM was not associated with distress outcomes at 12 months. CONCLUSIONS: Following a positive test result, 18% of women previously affected with unilateral breast cancer had a CPM. Women affected with breast cancer at a younger age, particularly those with positive genetic test results and higher cancer-specific distress, are more likely to choose CPM than women who receive uninformative test results and who are less distressed and older at diagnosis. CPM does not appear to impact distress outcomes.
BACKGROUND:Women affected with breast cancer who carry a BRCA1 or BRCA2 (BRCA1/2) mutation are at risk of developing contralateral breast cancer. To reduce the risk of contralateral breast cancer, some patients opt for prophylactic surgery of the unaffected breast (contralateral prophylactic mastectomy, CPM) in addition to mastectomy of the affected breast. METHODS: We conducted the present study to determine the predictors and outcomes of CPM in the year following BRCA1/2 genetic counseling and testing. Four hundred and thirty-five women affected with unilateral breast cancer who received positive or uninformative BRCA1/2 genetic test results completed assessments prior to genetic counseling and testing and 1, 6, and 12 months after receipt of results. RESULTS: Prior to testing, 16% had undergone CPM (in conjunction with mastectomy of the affected breast). In the year following testing, 18% with positive test results and 3% with uninformative test results opted for CPM. CPM following testing was associated with a positive genetic test result, younger age at cancer diagnosis [odds ratio (OR) = 0.94], and higher cancer-specific distress at baseline (OR = 3.28). CPM was not associated with distress outcomes at 12 months. CONCLUSIONS: Following a positive test result, 18% of women previously affected with unilateral breast cancer had a CPM. Women affected with breast cancer at a younger age, particularly those with positive genetic test results and higher cancer-specific distress, are more likely to choose CPM than women who receive uninformative test results and who are less distressed and older at diagnosis. CPM does not appear to impact distress outcomes.
Authors: Beth N Peshkin; Marc D Schwartz; Claudine Isaacs; Chanita Hughes; David Main; Caryn Lerman Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-10 Impact factor: 4.254
Authors: C M Julian-Reynier; L J Bouchard; D G Evans; F A Eisinger; W D Foulkes; B Kerr; I R Blancquaert; J P Moatti; H H Sobol Journal: Cancer Date: 2001-08-15 Impact factor: 6.860
Authors: S K McDonnell; D J Schaid; J L Myers; C S Grant; J H Donohue; J E Woods; M H Frost; J L Johnson; D L Sitta; J M Slezak; T B Crotty; R B Jenkins; T A Sellers; L C Hartmann Journal: J Clin Oncol Date: 2001-10-01 Impact factor: 44.544
Authors: C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch Journal: Prev Med Date: 2000-07 Impact factor: 4.018
Authors: Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit Journal: N Engl J Med Date: 2002-05-20 Impact factor: 91.245
Authors: Timothy R Rebbeck; Henry T Lynch; Susan L Neuhausen; Steven A Narod; Laura Van't Veer; Judy E Garber; Gareth Evans; Claudine Isaacs; Mary B Daly; Ellen Matloff; Olufunmilayo I Olopade; Barbara L Weber Journal: N Engl J Med Date: 2002-05-20 Impact factor: 91.245
Authors: Litanja N Lodder; Petra G Frets; R Willem Trijsburg; E Johanna Meijers-Heijboer; Jan G M Klijn; Caroline Seynaeve; Albertus N van Geel; Madeleine M A Tilanus; Carina C M Bartels; Leon C Verhoog; Cecile T M Brekelmans; Curt W Burger; Martinus F Niermeijer Journal: Breast Cancer Res Treat Date: 2002-05 Impact factor: 4.872
Authors: Patricia A Parker; Susan K Peterson; Isabelle Bedrosian; Melissa A Crosby; Yu Shen; Dalliah M Black; Gildy Babiera; Henry M Kuerer; Jun Ying; Wenli Dong; Scott B Cantor; Abenaa M Brewster Journal: Ann Surg Date: 2016-01 Impact factor: 12.969
Authors: Rachel Shapira; Erin Turbitt; Lori H Erby; Barbara B Biesecker; William M P Klein; Gillian W Hooker Journal: Fam Cancer Date: 2018-10 Impact factor: 2.375
Authors: Clara Nan-Hi Lee; Peter Anthony Ubel; Allison M Deal; Lillian Burdick Blizard; Karen R Sepucha; David W Ollila; Michael Patrick Pignone Journal: Ann Surg Date: 2016-12 Impact factor: 12.969
Authors: Kristi D Graves; Rhoda Gatammah; Beth N Peshkin; Ayelet Krieger; Christy Gell; Heiddis B Valdimarsdottir; Marc D Schwartz Journal: Fam Cancer Date: 2011-06 Impact factor: 2.375
Authors: Shoshana M Rosenberg; Michaela S Tracy; Meghan E Meyer; Karen Sepucha; Shari Gelber; Judi Hirshfield-Bartek; Susan Troyan; Monica Morrow; Lidia Schapira; Steven E Come; Eric P Winer; Ann H Partridge Journal: Ann Intern Med Date: 2013-09-17 Impact factor: 25.391
Authors: Suzanne C O'Neill; Christine Rini; Rachel E Goldsmith; Heiddis Valdimarsdottir; Lawrence H Cohen; Marc D Schwartz Journal: Psychooncology Date: 2009-10 Impact factor: 3.894
Authors: Bettina Meiser; Kathy Tucker; Michael Friedlander; Kristine Barlow-Stewart; Elizabeth Lobb; Christobel Saunders; Gillian Mitchell Journal: Breast Cancer Res Date: 2008-11-28 Impact factor: 6.466